|
NDC00019-1323-11
|
6505-01-313-9548
|
Ioversol And Iodine For Injectio |
Envirovac Inc
|
|
Quote
|
|
TRILAFON
|
6505-01-314-0761
|
Usp Perphenazine Tablets |
Goldline Laboratories Inc.
|
|
Quote
|
|
16300
|
6505-01-314-0761
|
Usp Perphenazine Tablets |
Goldline Laboratories Inc.
|
|
Quote
|
|
NDC00182-1865-01
|
6505-01-314-0761
|
Usp Perphenazine Tablets |
Goldline Laboratories Inc.
|
|
Quote
|
|
NDC00641-0482-25
|
6505-01-314-1155
|
Phenylephrine Hydrochloride Inje |
Elkins-sinn Inc
|
|
Quote
|
|
NDC00186-0742-31
|
6505-01-314-2716
|
Omeprazole Extended-release Caps |
Veterans Health
|
|
Quote
|
|
NDC00186-0742-31
|
6505-01-314-2716
|
Omeprazole Extended-release Caps |
Astra Pharmaceutical Products Inc
|
|
Quote
|
|
NDC00186-0742-31
|
6505-01-314-2716
|
Omeprazole Extended-release Caps |
Cardinal Health 100 Inc
|
|
Quote
|
|
NDC51079-0007-20
|
6505-01-314-2717
|
Omeprazole Extended-release Caps |
Mylan Institutional Inc.
|
|
Quote
|
|
NDC00186-0742-28
|
6505-01-314-2717
|
Omeprazole Extended-release Caps |
Astra Pharmaceutical Products Inc
|
|
Quote
|
|
NDC66685-0422-01
|
6505-01-314-2717
|
Omeprazole Extended-release Caps |
Bristol-myers Co
|
|
Quote
|
|
NDC00186-0742-82
|
6505-01-314-2717
|
Omeprazole Extended-release Caps |
Astra Pharmaceuticals Lp
|
|
Quote
|
|
NDC00006-0727-28
|
6505-01-314-2717
|
Omeprazole Extended-release Caps |
Merck Sharp & Dohme Corp.
|
|
Quote
|
|
NDC60505-0065-02
|
6505-01-314-2717
|
Omeprazole Extended-release Caps |
Falcon Pharmaceuticals Ltd
|
|
Quote
|
|
NDC00378-6150-01
|
6505-01-314-2717
|
Omeprazole Extended-release Caps |
Mylan Pharmaceuticals Inc
|
|
Quote
|
|
NDC62175-0118-37
|
6505-01-314-2717
|
Omeprazole Extended-release Caps |
Kremers Urban Llc
|
|
Quote
|
|
NDC00904-5684-61
|
6505-01-314-2717
|
Omeprazole Extended-release Caps |
The Harvard Drug Group L.l.c.,
|
|
Quote
|
|
NDC51079-0007-30
|
6505-01-314-2717
|
Omeprazole Extended-release Caps |
Mylan Pharmaceuticals Inc.
|
|
Quote
|
|
NDC68084-0128-01
|
6505-01-314-2717
|
Omeprazole Extended-release Caps |
Amerisource Health Services
|
|
Quote
|
|
NDC63739-0358-10
|
6505-01-314-2717
|
Omeprazole Extended-release Caps |
Mckesson Pharmacy Systems, Llc
|
|
Quote
|
|
9182-01
|
6505-01-314-2737
|
Nf Chloroform |
Avantor Performance Materials, Inc.
|
|
Quote
|
|
A89I208
|
6505-01-314-2737
|
Nf Chloroform |
Department of the Army
|
|
Quote
|
|
ESOPHO-CAT
|
6505-01-314-2738
|
Barium Sulfate Cream |
E-z-em Inc
|
|
Quote
|
|
738
|
6505-01-314-2738
|
Barium Sulfate Cream |
E-z-em Inc
|
|
Quote
|
|
TOPICORT
|
6505-01-314-2740
|
Usp Desoximetasone Ointment |
Taro Pharmaceuticals U.s.a., Inc.
|
|
Quote
|
|
TOPICORT OINTMENT
|
6505-01-314-2740
|
Usp Desoximetasone Ointment |
Taro Pharmaceuticals U.s.a., Inc.
|
|
Quote
|
|
NDC51672-1262-01
|
6505-01-314-2740
|
Usp Desoximetasone Ointment |
Taro Pharmaceuticals U.s.a., Inc.
|
|
Quote
|
|
NDC51672-5203-01
|
6505-01-314-2740
|
Usp Desoximetasone Ointment |
Taro Pharmaceuticals U.s.a., Inc.
|
|
Quote
|
|
PLATINOL-AQ
|
6505-01-314-4270
|
Cisplatin Injection |
Mead Johnson & Company, Llc
|
|
Quote
|
|
NDC00015-3220-22
|
6505-01-314-4270
|
Cisplatin Injection |
Mead Johnson & Company, Llc
|
|
Quote
|
|
3400957615772
|
6505-01-314-4270
|
Cisplatin Injection |
Accord Healthcare France Sas
|
|
Quote
|
|
CYTOSAR-U
|
6505-01-314-4278
|
Usp Cytarabine |
Pharmacia & Upjohn Company
|
|
Quote
|
|
NDC00009-0373-01
|
6505-01-314-4278
|
Usp Cytarabine |
Pharmacia & Upjohn Company
|
|
Quote
|
|
NDC00364-2467-53
|
6505-01-314-4278
|
Usp Cytarabine |
Schein Pharmaceutical Inc
|
|
Quote
|
|
ROCEPHIN ADDVANTAGE
|
6505-01-314-4279
|
Usp Ceftriaxone Sodium |
Roche Laboratories Inc.
|
|
Quote
|
|
NDC00004-1965-05
|
6505-01-314-4279
|
Usp Ceftriaxone Sodium |
Roche Laboratories Inc.
|
|
Quote
|
|
NDC00004-1965-05
|
6505-01-314-4279
|
Usp Ceftriaxone Sodium |
Cardinal Health 100 Inc
|
|
Quote
|
|
ROCEPHIN
|
6505-01-314-4280
|
Usp Ceftriaxone Sodium |
Roche Laboratories Inc.
|
|
Quote
|
|
ROCEPHIN ADDVANTAGE
|
6505-01-314-4280
|
Usp Ceftriaxone Sodium |
Roche Laboratories Inc.
|
|
Quote
|
|
NDC00004-1964-05
|
6505-01-314-4280
|
Usp Ceftriaxone Sodium |
Roche Laboratories Inc.
|
|
Quote
|
|
74521
|
6505-01-314-4280
|
Usp Ceftriaxone Sodium |
Roche Laboratories Inc.
|
|
Quote
|
|
NDC00004-1964-05
|
6505-01-314-4280
|
Usp Ceftriaxone Sodium |
Cardinal Health 200, Llc
|
|
Quote
|
|
NDC00409-7333-04
|
6505-01-314-4280
|
Usp Ceftriaxone Sodium |
Hospira, Inc.
|
|
Quote
|
|
ADD-VANTAGE
|
6505-01-314-4280
|
Usp Ceftriaxone Sodium |
Hospira, Inc.
|
|
Quote
|
|
SENSORCAINE
|
6505-01-314-5852
|
Bupivacaine Hydrochloride Inject |
Astra Pharmaceuticals Lp
|
|
Quote
|
|
NDC00186-1033-02
|
6505-01-314-5852
|
Bupivacaine Hydrochloride Inject |
Astra Pharmaceuticals Lp
|
|
Quote
|
|
VASOTEC TABLETS
|
6505-01-314-6028
|
Usp Enalapril Maleate Tablets |
Merck Sharp & Dohme Corp.
|
|
Quote
|
|
VASOTEC
|
6505-01-314-6028
|
Usp Enalapril Maleate Tablets |
Merck Sharp & Dohme Corp.
|
|
Quote
|
|
NDC00006-0713-28
|
6505-01-314-6028
|
Usp Enalapril Maleate Tablets |
Merck Sharp & Dohme Corp.
|
|
Quote
|
|
NDC00172-4197-10
|
6505-01-314-6028
|
Usp Enalapril Maleate Tablets |
Zenith Laboratories Inc
|
|
Quote
|
|
NDC00172-4197-10
|
6505-01-314-6028
|
Usp Enalapril Maleate Tablets |
Ivax Corp
|
|
Quote
|
|
NDC00172-4197-10
|
6505-01-314-6028
|
Usp Enalapril Maleate Tablets |
Goldline Laboratories Inc.
|
|
Quote
|
|
NDC00173-0178-55
|
6505-01-314-6640
|
Bupropion Hydrochloride Tablets |
Amerisourcebergen Drug Corporation
|
|
Quote
|
|
NDC00173-0178-55
|
6505-01-314-6640
|
Bupropion Hydrochloride Tablets |
Glaxo Wellcome Inc
|
|
Quote
|
|
WELLBUTRIN
|
6505-01-314-6640
|
Bupropion Hydrochloride Tablets |
Burroughs Wellcome Co
|
|
Quote
|
|
NDC00173-0178-55
|
6505-01-314-6640
|
Bupropion Hydrochloride Tablets |
Burroughs Wellcome Co
|
|
Quote
|
|
NDC00081-0178-55
|
6505-01-314-6640
|
Bupropion Hydrochloride Tablets |
Burroughs Wellcome Co
|
|
Quote
|
|
NDC00173-0177-55
|
6505-01-314-6641
|
Bupropion Hydrochloride Tablets |
Glaxo Wellcome Inc
|
|
Quote
|
|
977
|
6505-01-314-6641
|
Bupropion Hydrochloride Tablets |
Burroughs Wellcome Co
|
|
Quote
|
|
WELLBUTRIN
|
6505-01-314-6641
|
Bupropion Hydrochloride Tablets |
Burroughs Wellcome Co
|
|
Quote
|
|
NDC00173-0177-55
|
6505-01-314-6641
|
Bupropion Hydrochloride Tablets |
Burroughs Wellcome Co
|
|
Quote
|
|
NDC00081-0177-55
|
6505-01-314-6641
|
Bupropion Hydrochloride Tablets |
Burroughs Wellcome Co
|
|
Quote
|
|
PERGONAL
|
6505-01-314-6651
|
Usp Menotropins For Injection |
Serono-baker Diagnostics Inc
|
|
Quote
|
|
PERGONAL INJECTION
|
6505-01-314-6651
|
Usp Menotropins For Injection |
Serono-baker Diagnostics Inc
|
|
Quote
|
|
NDC44087-5075-03
|
6505-01-314-6651
|
Usp Menotropins For Injection |
Serono-baker Diagnostics Inc
|
|
Quote
|
|
TOPICORT LP CREAM
|
6505-01-314-6675
|
Usp Desoximetasone Cream |
Hoechst-roussel Pharmaceuticals Inc
|
|
Quote
|
|
NDC00039-0012-23
|
6505-01-314-6675
|
Usp Desoximetasone Cream |
Hoechst-roussel Pharmaceuticals Inc
|
|
Quote
|
|
NDC61748-0205-15
|
6505-01-314-6675
|
Usp Desoximetasone Cream |
Akorn, Inc.
|
|
Quote
|
|
NDC51672-1271-03
|
6505-01-314-6676
|
Usp Desoximetasone Cream |
Taro Pharmaceuticals U.s.a., Inc.
|
|
Quote
|
|
738
|
6505-01-314-6679
|
Barium Sulfate Cream |
E-z-em, Inc.
|
|
Quote
|
|
254108
|
6505-01-314-6679
|
Barium Sulfate Cream |
Philips Medical Systems Cleveland
|
|
Quote
|
|
254108
|
6505-01-314-6679
|
Barium Sulfate Cream |
Marconi Medical Systems Inc
|
|
Quote
|
|
F89J103
|
6505-01-314-6680
|
Povidone-iodine Cleansing Soluti |
Air Force Medical Logistics Office
|
|
Quote
|
|
29904-032
|
6505-01-314-6680
|
Povidone-iodine Cleansing Soluti |
Cardinal Health 200, Llc
|
|
Quote
|
|
29904-032
|
6505-01-314-6680
|
Povidone-iodine Cleansing Soluti |
Baxter Healthcare Corporation
|
|
Quote
|
|
NDC00409-7810-22
|
6505-01-314-6681
|
Dopamine Hydrochloride And Dextr |
Hospira, Inc.
|
|
Quote
|
|
A89J033
|
6505-01-314-6935
|
Sodium Chloride Inhalation Solut |
Department of the Army
|
|
Quote
|
|
116
|
6505-01-314-6935
|
Sodium Chloride Inhalation Solut |
Ballard Medical Products
|
|
Quote
|
|
6505NCM162857
|
6505-01-314-6935
|
Sodium Chloride Inhalation Solut |
Defense Medical Standardization
|
|
Quote
|
|
1410602
|
6505-01-314-6935
|
Sodium Chloride Inhalation Solut |
Defense Logistics Agency
|
|
Quote
|
|
116
|
6505-01-314-6935
|
Sodium Chloride Inhalation Solut |
Halyard Health, Inc.
|
|
Quote
|
|
PVON 1
|
6505-01-314-6935
|
Sodium Chloride Inhalation Solut |
Cardinal Health 200, Llc
|
|
Quote
|
|
INSTA-GLUCOSE
|
6505-01-314-9175
|
Glucose Gel |
Icn Pharmaceuticals Inc-us
|
|
Quote
|
|
NDC00187-0747-32
|
6505-01-314-9175
|
Glucose Gel |
Icn Pharmaceuticals Inc-us
|
|
Quote
|
|
NDC00054-0025-11
|
6505-01-315-1275
|
Mefloquine Hydrochloride Tablets |
Boehringer Ingelheim Roxane, Inc.
|
|
Quote
|
|
LARIAM
|
6505-01-315-1275
|
Mefloquine Hydrochloride Tablets |
Roche Laboratories Inc.
|
|
Quote
|
|
LARIAM TABLETS
|
6505-01-315-1275
|
Mefloquine Hydrochloride Tablets |
Roche Laboratories Inc.
|
|
Quote
|
|
NDC00004-0172-02
|
6505-01-315-1275
|
Mefloquine Hydrochloride Tablets |
Roche Laboratories Inc.
|
|
Quote
|
|
NDC00004-0172-02
|
6505-01-315-1275
|
Mefloquine Hydrochloride Tablets |
Cardinal Health 100 Inc
|
|
Quote
|
